The Effect of Initiating Intravenous Oxytocin Infusion before Uterine Incision on Blood Loss During Elective Caesarean Section: A Randomized Clinical Trial

Presurgery oxytocin trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202111830813291

Enrollment

180

Registered

2021-11-10

Start date

2019-09-02

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post partum haemorrhage prevention

Interventions

Group B

Group A

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: • Singleton pregnancy • Term pregnancy (37 - 42 weeks gestational age) • Booked for elective caesarean section, • Willingness to participate in the study, were included.

Exclusion criteria

Exclusion criteria: • Women with multiple gestation • Women with polyhydramnios or macrosomia • Parturients with antepartum haemorrhage • Parturients with heart or renal disease • Women with 2 or more previous CS • Women with bleeding disorders • Women with previous history of postpartum haemorrhage • Women who did not consent to the study

Design outcomes

Primary

Measure	Time frame
•The mean blood loss during elective caesarean section in the two arms	—

Secondary

Measure	Time frame
. The need for additional uterotonics to control bleeding • The need for blood transfusion or additional surgical intervention • Maternal side effects(nausea and vomiting, chest pain, palpitation, maternal death) • Neonatal outcomes of the study groups	—

Countries

Nigeria

Contacts

Public ContactEgede John Okafor

Consultant

egedejohno@gmail.com+2348037797950

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026